Drug Profile
Isovanihuperzine A
Alternative Names: IVHALatest Information Update: 30 May 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 25 Aug 1998 No-Development-Reported for Cognition disorders in China (Unknown route)
- 24 Jul 1996 Preclinical development for Cognition disorders in China (Unknown route)